Feature

Reprogramming the Immune System: Cancer Vaccines, Collaboration, and Communication

From the University of Houston to MD Anderson Cancer Center, Cole Woody’s journey shows how curiosity and collaboration can drive major discoveries. He reflects on the promise of repurposed mRNA vaccines, the technical art of immunology, and the social side of science.

  • November 25, 2025

  • 8 min

Share

Cole Woody, an undergraduate biology major at the University of Houston, contributed to significant research at MD Anderson Cancer Center showing that mRNA COVID-19 vaccines could double survival rates in cancer patients undergoing immunotherapy. His research indicates that these vaccines enhance immune response, leading to better outcomes. Although promising, Woody advises waiting for Phase III clinical trials before clinical implementation. His interest in cancer immunology stems from a fascination with the immune system, further fueled by mentorship and hands-on lab experience.

Related Content

Tracing Long-Term Radon Gas Exposure With… Toenails?

The surprising biological archive of past radon gas exposure that may help improve lung cancer screening

Access to Advanced Therapies Hinges on AI and Collaboration

AI and collaboration can transform cell and gene therapy by integrating data, improving manufacturing handoffs, and enabling personalized, scalable treatments.

Bringing New Ideas to AAV Gene Therapy

As safety concerns and commercial doubts threaten the AAV gene therapy field, new technologies may offer a “well-rounded” solution.